Anti-allergic action of anti-malarial drug artesunate in experimental mast cell-mediated anaphylactic models

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 2, 2013, Pages 195-203

  Cheng, C ^a   Ng, D S W ^a   Chan, T K ^a   Guan, S P ^a   Ho, W E ^b   Koh, A H M ^a   Bian, J S ^a   Lau, H Y A ^c   Wong, W S F ^a,d  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c Chinese University of Hong Kong   (Hong Kong)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

anaphylactic contraction; Ca2+ imaging; passive cutaneous anaphylaxis; passive systemic anaphylaxis; phospholipase C 1; Syk kinase

Indexed keywords

ANTIALLERGIC AGENT; ARTESUNATE; CALCIUM; HISTAMINE; IMMUNOGLOBULIN E; OVALBUMIN; PROTEIN KINASE SYK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS MUSCLE; CONCENTRATION RESPONSE; FEMALE; GUINEA PIG; HISTAMINE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPOTHERMIA; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE CONTRACTION;

ANAPHYLAXIS; ANIMALS; ANTI-ALLERGIC AGENTS; ANTIMALARIALS; ARTEMISININS; ASTHMA; CELL DEGRANULATION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HUMANS; IMMUNITY, CELLULAR; IMMUNOBLOTTING; IMMUNOGLOBULIN E; MAST CELLS; MICE; RANDOM ALLOCATION;

EID: 84872375416     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12077     Document Type: Article

References (42)

1. Galli SJ, Tsai M, Piliponsky AM,. The development of allergic inflammation. Nature 2008; 454: 445-454.
2. Simons FER,. Anaphylaxis. J Allergy Clin Immunol 2010; 125: S161-S181.
3. Bradding P, Walls AF, Holgate ST,. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 2006; 117: 1277-1284.
4. Kalesnikoff J, Galli SJ,. Anaphylaxis: mechanisms of mast cell activation. Chem Immunol Allergy 2010; 95: 45-66.
5. Metcalfe DD, Peavy RD, Gilfillan AM,. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol 2009; 124: 639-646.
6. Nishida K, Yamasaki S, Ito Y, Kabu K, Hattori K, Tezuka T, et al. FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J Cell Biol 2005; 170: 115-126.
7. Yoko M-K, Yoshio H, Tetsuya A, Satsuki I-S, Yoshihiro K, Yutaka K, et al. The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J Allergy Clin Immunol 2002; 110: 298-303.
8. Woodrow CJ, Haynes RK, Krishna S,. Artemisinins. Postgrad Med J 2005; 81: 71-78.
9. Rosenthal PJ,. Artesunate for the treatment of severe falciparum malaria. N Engl J Med 2008; 358: 1829-1836.
10. Krishna S, Bustamante L, Haynes RK, Staines HM,. Artemisinins: their growing importance in medicine. Trends Pharmacol Sci 2008; 29: 520-527.
11. Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJG, Marschall M,. The antiviral activities of artemisinin and artesunate. Clin Infect Dis 2008; 47: 804-811.
12. Xu H, He Y, Yang X, Liang L, Zhan Z, Ye Y, et al. Anti-malarial agent artesunate inhibits TNF-α-induced production of proinflammatory cytokines via inhibition of NF-κB and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology 2007; 46: 920-926.
13. Cheng C, Ho WE, Goh FY, Guan SP, Kong LR, Lai W-Q, et al. Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway. PLoS ONE 2011; 6: e20932.
14. Hsu CL, Neilsen CV, Bryce PJ,. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS ONE 2010; 8: e11944.
15. Pedotti R, Sanna M, Tsai M, DeVoss J, Steinman L, McDevitt H, et al. Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type I diabetes mellitus. BMC Immunol 2003; 4: 2.
16. Duan W, Kuo IC, Selvarajan S, Chua KY, Bay BH, Wong WSF,. Anti-inflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med 2003; 167: 185-192.
17. Tsang F, Wong WSF,. Inhibitors of tyrosine kinase signaling cascade attenuated antigen challenge of guinea pig airways in vitro. Am J Respir Crit Care Med 2000; 162: 126-133.
18. Begueret H, Berger P, Vernejoux JM, Dubuisson L, Marthan R, Tunon-de-Lara JM,. Inflammation of bronchial smooth muscle in allergic asthma. Thorax 2007; 62: 8-15.
19. Chan JHP, Liao W, Lau HYA, Wong WSF,. Gab2 antisense oligonucleotides blocks mast cell functions. Int Immunopharmacol 2007; 7: 937-944.
20. Wang XS, Yip KH, Sam SW, Lau HYA,. Buffy coat preparation is a convenient source of progenitors for culturing mature human mast cells. J Immunol Methods 2006; 309: 69-74.
21. 2S preconditioning-induced PKC activation regulates intracellular calcium handling in rat cardiomyocytes. Am J Physiol Cell Physiol 2008; 294: C169-C177.
22. Li Q, Cantilena LR, Leary KJ, Saviolakis GA, Miller RS, Melendez V, et al. Pharmacokinetic profiles of artesunate after single intravenous doses at 0.5, 1, 2, 4, and 8 mg/kg in healthy volunteers: a phase I study. Am J Trop Med Hyg 2009; 81: 615-621.
23. Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin CS, Fleckenstein L,. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malaria J 2011; 10: 263.
24. Roquet A, Dahlen B, Kumlin M, Ihre E, Anstren G, Binks S, et al. Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 1997; 155: 1856-1863.
25. Ishijima Y, Ohmori S, Uenishi A, Ohneda K,. GATA transcription factors are involved in IgE-dependent mast cell degranulation by enhancing the expression of phospholipase C-γ1. Genes Cells 2012; 17: 285-301.
26. Inagaki N, Nagai H,. Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment: mouse models for the development of remedies for human allergic dermatitis. J Pharmacol Sci 2009; 110: 251-259.
27. Finkelman FD,. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 2007; 120: 506-515.
28. Kumar P, Shen Q, Pivetti CD, Lee ES, Wu MH, Yuan SY,. Molecular mechanisms of endothelial hyperpermeability: implications in inflammation. Expert Rev Mol Med 2009; 11: e19.
29. Evora PRB, Simon MR,. Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue. Ann Allergy Asthma Immunol 2007; 99: 306-313.
30. Passante E, Frankish N,. The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell. Inflamm Res 2009; 58: 737-745.
31. Forsythe P, Ennis M,. Clinical consequences of mast cell heterogeneity. Inflamm Res 2000; 49: 147-154.
32. Moon TC, Laurent CD, Morris KE, Marcet C, Yoshimura T, Sekar Y, et al. Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal Immunol 2009; 3: 111-128.
33. Siraganian RP, de Castro RO, Barbu EA, Zhang J,. Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett 2010; 584: 4933-4940.
34. Sanderson MP, Gelling SJ, Rippmann JF, Schnapp A,. Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcεRI-activated RBL-2H3 basophilic cells. Cell Immunol 2010; 262: 28-34.
35. Villoutreix BO, Lasconde G, Lagorce D, Martineau P, Miteva MA, Dariavach P,. Tyrosine kinase Syk non-enzymatic inhibitors and potential anti-allergic drug-like compounds discovered by virtual and in vitro screening. PLoS ONE 2011; 6: e21117.
36. Patou J, Holtappels G, Affleck K, van Cauwenberge P, Bachert C,. Syk-kinase inhibition prevents mast cell activation in nasal polyps. Rhinology 2011; 49: 100-106.
37. Kageyama-Yahara N, Wang X, Katagiri T, Wang P, Yamamoto T, Tominaga M, et al. Suppression of phospholipase Cγ1 phosphorylation by cinnamaldehyde inhibits antigen-induced extracellular calcium influx and degranulation in mucosal mast cells. Biochem Biophys Res Commun 2011; 416: 283-288.
38. Olivera A, Eisner C, Kitamura Y, Dillahunt S, Allende L, Tuymetova G, et al. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest 2010; 120: 1429-1440.
39. Ho WE, Cheng C, Peh HY, Xu F, Tannenbaum SR, Ong CN, et al. Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma. Free Radic Biol Med 2012; 53: 498-507.
40. Leonardi E, Gilvary G, White NJ, Nosten F,. Severe allergic reactions to oral artesunate: a report of two cases. Trans R Soc Trop Med Hyg 2001; 95: 182-183.
41. Dube SK, Panda PS, Agrawal GR, Singh DK,. Anaphylaxis to artesunate? Indian J Crit Care Med 2012; 16: 55-57.
42. Mohapatra MK, Srinivas D, Kar AK, Murmu M,. Anaphylactic reaction to intravenous artesunate. J Assoc Physicians India 2009; 57: 183-184.